Efficacy and Safety of Shufeng Jiedu Capsules in the Adjuvant Treatment of Community-acquired Pneumonia in Adult: a Meta-analysis

Efficacy and Safety of Shufeng Jiedu Capsules in the Adjuvant Treatment of Community-acquired Pneumonia in Adult: a Meta-analysis

Background Community-acquired pneumonia (CAP) is one of the common infectious diseases with high morbidity and heavy disease burden. Despite the continuous advancement of diagnostic technology and the launch of new antimicrobial drugs, the morbidity and mortality of CAP are still high. The clinical...

Full description

Bibliographic Details
Main Author:	Jiang YANG, Xuanlin LI, Jianxin WANG, Yang XIE, Huiguo LIU, Suyun LI, Minghang WANG
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2022-08-01
Series:	Zhongguo quanke yixue
Subjects:	community-acquired pneumonia\|shufeng jiedu capsules\|treatment outcome\|meta-analysis
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220124.pdf

Similar Items

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xiao-Wen Zhang, et al.
Published: (2022-07-01)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
by: Xiaodi Sheng, et al.
Published: (2022-10-01)

Shufeng Jiedu Capsules Alleviate Lipopolysaccharide-Induced Acute Lung Inflammatory Injury via Activation of GPR18 by Verbenalin
by: Ying Yuan, et al.
Published: (2018-10-01)

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
by: Yanqi Han, et al.
Published: (2023-04-01)

Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
by: Chun-li Lu, et al.
Published: (2024-05-01)

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
by: Merlin L. Willcox, et al.
Published: (2023-09-01)

Guideline on treating community-acquired pneumonia with Chinese patent medicines
by: Minghang Wang, et al.
Published: (2023-10-01)

Anti-tumor effect of Huayu Jiedu formula on SGC-7901 cancer cell
by: Wei Zheng, et al.
Published: (2016-02-01)

Shufeng Jiedu capsule alleviates influenza A (H1N1) virus induced acute lung injury by regulating the lung inflammatory microenvironment
by: Xiaorui Wang, et al.
Published: (2024-06-01)

Rujin Jiedu decoction protects against influenza virus infection by modulating gut microbiota
by: Qilin Huang, et al.
Published: (2024-07-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

Study on the function of Huazhuo Jiedu Decoction in promoting the homing of bone marrow mesenchymal stem cells and contributing to the treatment of ulcerative colitis
by: Yumei Ma, et al.
Published: (2023-08-01)

In vitro and in vivo antiviral effect of Fufang Yinhua Jiedu granules (FFYH) combined with oseltamivir against influenza A virus
by: Zhihui Zheng, et al.
Published: (2023-02-01)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
by: Yuqing Xie, et al.
Published: (2023-02-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription
by: Xie Y, et al.
Published: (2025-03-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
by: Wenli Qiu, et al.
Published: (2022-09-01)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023-02-01)

Effect and safety analysis of Yiqi Yangxue Jiedu decoction combined with entecavir in the treatment of male patients with decompensated hepatitis B cirrhosis
by: Mingli Jia
Published: (2025-02-01)

chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
by: hayfaa D. Salman
Published: (2009-01-01)

Mechanism of Gynecological Tiaoqi Jiedu Formula in Treatment of Endometritis with Dampness and Heat: A Prospective Laboratory-Based Mice Model Study
by: Jixiang Chen, et al.
Published: (2023-12-01)

Evaluation Study of Traditional Chinese Medicine Syndrome Differentiation Therapy on the Quality of Life and Efficacy Satisfaction in Elderly Community-acquired Pneumonia Patients after Discharge
by: WANG Minghang, HAN Weihong, BI Lichan, YANG Jiang, LI Jiansheng
Published: (2024-03-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

Jiedu Fuzheng decoction improves the proliferation, migration, invasion and EMT of non-small cell lung cancer via the Wnt/β-catenin pathway
by: Fang Fang, et al.
Published: (2023-12-01)

Yiqi Huayu Jiedu Decoction reduces colorectal cancer liver metastasis by promoting N1 neutrophil chemotaxis
by: Hua-Jian Zhou, et al.
Published: (2025-02-01)

Jianpi Jiedu decoction reverses 5-fluorouracil resistance in colorectal cancer by suppressing the xCT/GSH/GPX4 axis to induce ferroptosis
by: Qin-ling Ou, et al.
Published: (2024-03-01)

Integrated gut microbiota and metabolome analysis reveals the mechanism of Xiaoai Jiedu recipe in ameliorating colorectal cancer
by: Wenli Qiu, et al.
Published: (2023-06-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Тhe features of severe community acquired pneumonia.
by: I. V. Avramenko
Published: (2015-06-01)

Analysis of risk factors for hospital-acquired pneumonia in schizophrenia
by: Yu-hang Chen, et al.
Published: (2024-08-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
by: Mariana Lopes, et al.
Published: (2021-01-01)

Baoyuan Jiedu decoction alleviating cancer cachexia–Induced muscle atrophy by regulating muscle mitochondrial function in ApcMin/+ mice
by: Beiying Zhang, et al.
Published: (2022-08-01)

Therapeutic effects of Huayu Jiedu formula on endometriosis via downregulating GATA 6 expression
by: Wen Cheng, et al.
Published: (2024-01-01)

The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-01-01)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
by: Catia Cillóniz, et al.
Published: (2018-04-01)

Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway
by: Zhuo Lu, et al.
Published: (2020-05-01)

Modern characteristics of publicly acquired pneumonia caused by Clamydophyla pneumoniae
by: A. I. Danilov, et al.
Published: (2021-06-01)